Thalidomide analogs and PDE4 inhibition. (Record no. 9836019)

MARC details
000 -LEADER
fixed length control field 01412 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513160551.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199902s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0960-894X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/s0960-894x(98)00475-2
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Muller, G W
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19990202
245 00 - TITLE STATEMENT
Title Thalidomide analogs and PDE4 inhibition.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Bioorganic & medicinal chemistry letters
Date of publication, distribution, etc. Oct 1998
300 ## - PHYSICAL DESCRIPTION
Extent 2669-74 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element 3',5'-Cyclic-AMP Phosphodiesterases
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclic Nucleotide Phosphodiesterases, Type 4
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukocytes, Mononuclear
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lipopolysaccharides
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phosphodiesterase Inhibitors
General subdivision chemistry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Structure-Activity Relationship
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thalidomide
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Cells, Cultured
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Necrosis Factor-alpha
General subdivision antagonists & inhibitors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shire, M G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wong, L M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Corral, L G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Patterson, R T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chen, Y
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stirling, D I
773 0# - HOST ITEM ENTRY
Title Bioorganic & medicinal chemistry letters
Related parts vol. 8
-- no. 19
-- p. 2669-74
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/s0960-894x(98)00475-2">https://doi.org/10.1016/s0960-894x(98)00475-2</a>
Public note Available from publisher's website

No items available.